Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial - Concepedia

Concepedia

Publication | Open Access

Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial

DOI Full Paper Access

45

Citations

23

References

2017

Year

Jobst C. von Einem, Sylvia Peter, Christine Günther, Hans‐Dieter Volk, Gerald Grütz, Christoph Salat, Oliver J. Stoetzer, Peter J. Nelson, Marlies Michl, Dominik Paul Modest,

Abstract

Treatment with MSC_apceth_101 in combination with GCV demonstrated acceptable safety and tolerability in patients with advanced gastrointestinal adenocarcinoma.

References

	Year	Citations

Page 1